Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Lignocellulosic biomass is a flexible renewable useful resource for fuels, buildings, crafts, and biomaterials. Strategies of molecularly designing lignocellulose for industrial software has been developed by the discoveries of novel genes after the screenings of varied mutants and remodeled traces of Arabidopsis whose cell partitions might be modified in the inflorescence stem, a mannequin woody tissue. The mechanical properties are used as a quantitative index for the chemorehological conduct of the genetically modified cell wall in the tissue.

This parameter could be measured with tensile or bending checks of tissue explants, the vibration evaluation of tissue conduct or utilizing atomic power microscopy to probe the tissue floor. Here, we describe in element the process to find out the stiffness of methanol-fixed, rehydrated and pronase-treated inflorescence explants with a tensile testing machine primarily based on classical strategies for the dedication of cell wall extensibility.

Extracellular matrix (ECM)-based tissue engineering scaffolds have a necessary position in selling tissue regeneration. Nerve tissue engineering goals at facilitating the restore of everlasting injury to the peripheral and central nervous methods, that are tough to heal. For this function, a range of biomaterials are being developed consisting of quite a few artificial and/or pure polymers to offer axonal reinnervation and to direct the development of axons. Here, we current a novel protocol that permits to manufacture a three-d (3D) decellularized scaffold derived from the bovine spinal twine (BSC) ECM (3D-dCBS) for neural tissue engineering purposes.

In this protocol, a viscous ECM-derived gel from BSC is ready, molded, and chemically crosslinked with EDC/NHS (3D-CBS) earlier than decellularization course of. Decellularization of 3D-CBS is carried out with 1% SDS to realize 3D-dCBS. As in contrast with different out there strategies, our protocol is a novel decellularization technique that preserves a extra important half of the ECM. We imagine that the talked about protocol has the potential to supply a bioengineered scaffold from spinal twine tissue with desired geometry for regenerative drugs purposes associated to neural tissue engineering.

The Fabrication of Poly( Σ-caprolactone)-Poly(ethylene oxide) Sandwich Type Nanofibers Containing Sericin-Capped Silver Nanoparticles as an Antibacterial Wound Dressing

In this examine, antibacterial, artificial poly(Σ-caprolactone)-poly(ethylene oxide) (PCL-PEO) multilayer nanofibers had been produced by an electrospinning technique. The materials was synthesized in Three layers. The upper-lower protecting layers had been produced by PCL nanofibers and the intermediate layer was produced from PEO nanofiber containing sericin-capped silver nanoparticles (S-AgNPs). The electrospinning circumstances in which nano-sized, clean, bead-free fibers had been obtained was decided to be an utilized voltage of 20 kV, a circulate price of 8 μL/min and a distance between the collector and the needle tip of 22 cm for the PCL layer (dissolved at a 12% g/mL focus in a chloroform:methanol (3:2) solvent combination) layer.

For the S-AgNPs doped PEO layer (dissolved at a 3.5% g/mL focus in water), the corresponding circumstances had been decided to be 20 kV, 15 μL/min and 20 cm.To characterize the three-layer materials that consisted of PCL and S-AgNPs doped PEO layers, FTIR and SEM analyses had been carried out, and the water retention capability, in situ degradability and antibacterial exercise of the materials was investigated.

According to SEM evaluation, the fibers obtained had been discovered to be nano-sized, clean and bead-free and the common measurement of the nanofibers forming the PCL layer was 687 nm whereas the common measurement of the fibers forming the PEO layer was 98 nm. Antibacterial exercise checks had been carried out utilizing gram-positive (Staphylococcus aureus ATCC 6538) and gram-negative (Escherichia coli ATCC 25922) micro organism and the ensuing biomaterial was discovered to have antimicrobial impact on each gram-negative and gram-positive micro organism. It was decided that the 3-layer materials obtained in this examine can be utilized as a wound dressing.

 Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Peptide-Chitosan Engineered Scaffolds for Biomedical Applications

Peptides are signaling epitopes that management many important organic occasions. Increased specificity, artificial feasibility with concomitant lack of toxicity, and immunogenicity make this rising class of biomolecules appropriate for totally different purposes together with therapeutics, diagnostics, and biomedical engineering. Further, chitosan, a naturally occurring linear polymer composed of d-glucosamine and N-acetyl-d-glucosamine items, possesses anti-microbial, muco-adhesive, and hemostatic properties together with wonderful biocompatibility.

As a end result, chitosan finds software in drug/gene supply, tissue engineering, and bioimaging. Despite these purposes, chitosan demonstrates restricted cell adhesion and lacks biosignaling. Therefore, peptide-chitosan hybrids have emerged as a brand new class of biomaterial with improved biosignaling properties and cell adhesion properties. As a end result, current research embody elevated software of peptide-chitosan hybrids as composites or conjugates in drug supply, cell remedy, and tissue engineering and as anti-microbial materials. This evaluate discusses the current investigations involving chitosan-peptide supplies and uncovers varied facets of these attention-grabbing hybrid supplies for biomedical purposes.

Tetanus Toxoid scFv Antibody

abx137499-100tests 100 tests
EUR 225

FMC63 scFv, His Tag (SPR verified)

CD9-M52Hb 100ug
EUR 1487.3
Description: FMC63 scFv, His Tag (CD9-M52Hb) is expressed from human 293 cells (HEK293). It mimics the scFv presented on CAR-T cells which target CD19.

Recombinant (E.Coli) Anti-p53 scFv IgG

RP-341 10 ug
EUR 343.2

pHrdSV40- scFv- GCN4- sfGFP- VP64- GB1- NLS

PVT10950 2 ug
EUR 361.2

Anti-TNFRSF8 (clone Ki4) scFv-MAP ADC

ADC-W-354 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (clone Ki4) conjugated via a linker to a MAP

Recombinant (E.Coli) Anti-Tetanus Toxoid scFv IgG

RP-343 10 ug
EUR 343.2

Anti-ROR1 (clone R11) scFv-Fc-Sec ADC

ADC-W-434 1mg Ask for price
Description: This ADC product is comprised of an anti-ROR1 scFv-Fc (clone R11) conjugated via a engineered selenocysteine (Sec) residue linker to a drug

SARS-CoV-2 Nucleocapsid Protein scFv Antibody

abx229488-100g 100 µg
EUR 1725

Anti-COVID-19 Nucleocapsid Protein scFv Antibody

E38A9964 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Biotinylated FMC63 scFv, Fc,Avitag™ (MALS verified)

CD9-BV4324b 25ug
EUR 1294.7
Description: Biotinylated FMC63 scFv, Fc, Avitag is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain.

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56

CABT-Z294M 25 tests; 250 tests Ask for price
Description: Mouse

E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody

DL99719A-100ul 100 ul
EUR 299
Description: Nucleoprotein; Nucleocapsid protein; NC; Protein N

E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody

DL99719A-50ul 50 ul
EUR 210
Description: Nucleoprotein; Nucleocapsid protein; NC; Protein N

SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV)

E-AB-V1012-1mg 1mg
EUR 9200
Description: Unconjugated

SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV)

E-AB-V1012-each each Ask for price
Description: Unconjugated

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [PE]

CABT-Z293M 25 tests
EUR 840
Description: Mouse

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [FITC]

CABT-Z296M 25 tests; 200 tests Ask for price
Description: Mouse

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [Biotin]

CABT-Z295M 25 tests; 200 tests Ask for price
Description: Mouse

Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ)

78600 50 µl
EUR 1150
Description: The anti-CD19 CAR lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express the ScFv portion of anti-CD19 (clone FMC63) linked to 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge, 4-1BB, and CD3ζ signaling domains. 

AS Control

A26 -
EUR 330
Description: SW module for AS control

GC Control

A23 -
EUR 600
Description: SW module for GC control

LC Control

A24 -
EUR 600
Description: SW module for HPLC/CE control (pump, det, etc.)

Rat Control

DEV99RC 2 x 1 ml
EUR 60

MDP control

tlrl-mdpcl 5 mg
EUR 148.05

Rat neurofascin (Nfasc)-control Control/blocking peptide

AB-23249-CP 100ug
EUR 196.8

pMD18- Control

PVT10563 2 ug
EUR 319.2

pMD19- Control

PVT10564 2 ug
EUR 319.2

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 242.4

Control Slides

24012-1 1box
EUR 78

Canine Control

DEV99CC 2 x 1 ml
EUR 60

Dengue Control

ant-543 100µg
EUR 165
Description: Mouse Anti-Dengue Control for Lateral Flow Test

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 196.8

Quality Control

abx098966-1vial 1 vial
EUR 360

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 196.8

PIPET CONTROLLER CONTROL BOARD

357484 1/pk
EUR 104.4
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 123.6

ODN 2088 control

tlrl-2088c-1 1 mg
EUR 546

ODN 2395 control

tlrl-2395c-1 1 mg
EUR 546

Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control

TYROSIN081 1.5mm
EUR 50

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Control siRNA Vector (pGB-control)

9500C-20 each
EUR 405.6

Anti-Amyloid Beta Reference Antibody (CSIRO anti-amyloid Beta scFv)

E24CHA691 100 μg
EUR 225
Description: Available in various conjugation types.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-079-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-079-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv)

BSFV-102-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv)

BSFV-102-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

OOSA10387-100T - IgM NEGATIVE CONTROL Negative/Isotype Control

OOSA10387-100T 100Tests
EUR 309

OOSA10342-100UG - IgG1 NEGATIVE CONTROL Negative/Isotype Control

OOSA10342-100UG 0.1mg
EUR 219

OOSA10349-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control

OOSA10349-100T 100Tests
EUR 299

OOSA10380-100T - IgG2b NEGATIVE CONTROL Negative/Isotype Control

OOSA10380-100T 100Tests
EUR 309

OOSA10389-100T - IgG1 NEGATIVE CONTROL Negative/Isotype Control

OOSA10389-100T 100Tests
EUR 309

OOSA10397-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control

OOSA10397-100T 100Tests
EUR 309

Control FD BNP

K023M-6 6 x 1 mL
EUR 292
Description: Bi-Level

Control FD TDM

K068M-6 6 x 5 mL
EUR 205
Description: Tri-Level

Anti-CD22 CAR Lentivirus (Clone m971 ScFv-CD8-4-1BB-CD3ζ)

78608 50 µl
EUR 1095
Description: The anti-CD22 CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain variable fragment) of anti-CD22 (clone m971) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (below).

Control for Mammaglobin, 4 cases (1.5mm)HumanBreastBreastIHC control

MAMA-G081 1.5mm
EUR 50

EDG-1 Control

BC-009 100 uL
EUR 350

EDG-2 Control

BC-011 100 uL
EUR 350

EDG-4 Control

BC-012 100 uL
EUR 350

EDG-6 Control

BC-014 100 uL
EUR 350

EDG-7 Control

BC-016 100 uL
EUR 350

Rat Control IgG

AC034 100 ul
EUR 159.6

β-Gal Control

LV007 4 x 500 ul
EUR 195

NF-κB Control

T37559-10mg 10mg Ask for price
Description: NF-κB Control

NF-κB Control

T37559-1g 1g Ask for price
Description: NF-κB Control

NF-κB Control

T37559-1mg 1mg Ask for price
Description: NF-κB Control

NF-κB Control

T37559-50mg 50mg Ask for price
Description: NF-κB Control

NF-κB Control

T37559-5mg 5mg Ask for price
Description: NF-κB Control

Anti-BCMA CAR Lentivirus (Clone C11D5.3 ScFv-CD8-4-1BB-CD3ζ)

78655 50 µl
EUR 1095
Description: The anti-BCMA CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain variable fragment) of anti-BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). The lentiviruses also transduce a puromycin selection gene.

Goat IgG control

31R-AG001 1 mg
EUR 104
Description: Goat Immunoglobulins Goat IgG control

Goat IgG Control

GT15900 1 mg
EUR 199.2

2'3'-cGAMP Control

tlrl-nagpap 1 mg
EUR 235.2

G3-YSD Control

tlrl-ydnac 200 µg
EUR 148.05

Rat IgG1 Control

mabg1-ctlrt 100 µg Ask for price

MG-BSA Control

STA-306 100 µg
EUR 386.4
Description:
  • Methylglyoxal-BSA (MG-BSA) may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL

Control for GCDFP-15, 4 cases (1.5mm)HumanBreastBreastIHC control

GCDFP081 1.5mm
EUR 50

Mouse IgG Control

10R-I169A 250 ug
EUR 104
Description: Mouse Immunoglobulins Mouse IgG Control

human IgM control

E4A11C04 50ug
EUR 255
Description: Available in various conjugation types.

human IgE control

E4A11C05 50ug
EUR 255
Description: Available in various conjugation types.

Mouse Control IgG

AC011 100 ul
EUR 143
Description: None

Mouse IgM Control

ICIGMF-100 100 µg
EUR 239.4

Mouse IgM Control

ICIGMPU-100 100 µg
EUR 239.4

ISD Control Naked

tlrl-isdcn 200 µg
EUR 148.05

Rat IgG2a Control

mabg2a-ctlrt 100 µg
EUR 101.85

Rat IgG2a Control

mabg2a-ctlrt-05 5 x 100 µg
EUR 163.8

Rat IgG2b Control

mabg2b-ctlrt 100 µg Ask for price

CEL-BSA Control

STA-302 100 µg
EUR 245

CML-BSA Control

STA-314 100 µg
EUR 386.4
Description:
  • CML-BSA may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

MDA-BSA Control

STA-333 100 µg
EUR 245

HNE-BSA Control

STA-335 100 µg
EUR 245

human IgM control

E4A11D04 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human IgE control

E4A11D05 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

OOSA10361-1ML - Rat IgG2a NEGATIVE CONTROL Negative/Isotype Control

OOSA10361-1ML 1ml
EUR 169

Control for MSH2, 4 cases (1.5mm)HumanDigestive systemColonIHC control

MSH2081 1.5mm
EUR 50

Control for Olig2, 4 cases (1.5mm)HumanNervous systemBrainIHC control

OLIG2081 1.5mm
EUR 50

Rabbit IgG Control

31R-AR001 500 ug
EUR 94
Description: Purified Normal Rabbit IgG

human IgG1 control

E4A11C03 50ug
EUR 255
Description: Available in various conjugation types.

Rabbit Control IgG

AC005 100 ul
EUR 143
Description: A synthetic peptide corresponding to Actin (plant specific).

Human IgG1 Control

HY-P9900 5mg
EUR 776.4

Mouse IgG1 Control

ICIGG1AC750-50 50 µg
EUR 855.6

Mouse IgG1 Control

ICIGG1PU-100 100 µg
EUR 239.4

Mouse IgG3 Control

ICIGG3CFB-100 100 µg
EUR 465.6

CD3 Control Slides

ICS2005-25 25 Slides
EUR 137.81

CD5 Control Slides

ICS2006-25 25 Slides
EUR 137.81

CD8 Control Slides

ICS2007-25 25 Slides
EUR 137.81

CEA Control Slides

ICS2012-25 25 Slides
EUR 137.81

EMA Control Slides

ICS2018-25 25 Slides
EUR 137.81

LCA Control Slides

ICS2029-25 25 Slides
EUR 137.81

NSE Control Slides

ICS2031-25 25 Slides
EUR 137.81

PSA Control Slides

ICS2033-25 25 Slides
EUR 137.81

PAS Control Slides

HCS1016-25 25 Slides
EUR 137.81

Rabbit IgG Control

GWB-DLRABG 0.5 mg Ask for price

ODN TTAGGG control

tlrl-ttagc-1 1 mg
EUR 546

Human IgA2 Control

maba2-ctrl 100 µg
EUR 101.85

Human IgA2 Control

maba2-ctrl-05 5 x 100 µg
EUR 163.8

Mouse Control IgG1

mabg1-ctrlm 100 µg
EUR 99.75

Mouse Control IgG1

mabg1-ctrlm-05 5 x 100 µg
EUR 163.8

Due to the lack of vascular distribution and the sluggish metabolism, cartilage tissue can’t restore itself, which stays an enormous problem for cartilage regeneration. Tissue engineering utilizing stem cells seems to be a promising technique for cartilage restore. Tissue engineers demonstrated that mechanical stimulation can improve the high quality of engineered cartilage, making it extra much like pure cartilage in construction and performance. In this evaluate, we summarize current research on the position of mechanical stimuli in chondrogenesis, specializing in the purposes of extrinsic mechanical loading and the research on mechanical properties of biomaterials in cartilage tissue engineering. This evaluate will present contemporary insights into the potential use of mechanical stimuli for scientific use.


A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

Hydrogels are hydrophilic 3D networks which might be capable of ingest massive quantities of water or organic fluids, and are potential candidates for biosensors, drug supply vectors, vitality harvester gadgets, and carriers or matrices for cells in tissue engineering. Natural polymers, e.g., cellulose, chitosan and starch, have glorious properties that afford fabrication of superior hydrogel supplies for biomedical functions: biodegradability, biocompatibility, non-toxicity, hydrophilicity, thermal and chemical stability, and the excessive capability for swelling induced by facile artificial modification, amongst different physicochemical properties.

Hydrogels require variable time to succeed in an equilibrium swelling as a result of the variable diffusion charges of water sorption, capillary motion, and different modalities. In this examine, the nature, transport kinetics, and the function of water in the formation and structural stability of numerous varieties of hydrogels comprised of pure polymers are reviewed.Since water is an integral half of hydrogels that represent a substantive portion of its composition, there’s a must receive an improved understanding of the function of hydration in the construction, diploma of swelling and the mechanical stability of such biomaterial hydrogels.

The capability of the polymer chains to swell in an aqueous solvent will be expressed by the rubber elasticity concept and different thermodynamic contributions; whereas the charge of water diffusion will be pushed both by focus gradient or chemical potential. An overview of fabrication methods for numerous varieties of hydrogels is offered in addition to their responsiveness to exterior stimuli, together with their potential utility in numerous and novel functions. This overview goals to shed gentle on the function of hydration to the construction and perform of hydrogels. In flip, this overview will additional contribute to the improvement of superior supplies, reminiscent of “injectable hydrogels” and super-adsorbents for functions in the subject of environmental science and biomedicine.

Formation of contractile 3D bovine muscle tissue for development of millimetre-thick cultured steak

Owing to the enhance in the international demand of meat, cultured meat expertise is being developed to bypass a scarcity of meat in the future. However, strategies for development of millimetre-thick bovine muscle tissues with extremely aligned myotubes haven’t but been established. Here, we suggest a tradition technique for establishing 3D-cultured bovine muscle tissue containing myotubes aligned alongside its long-axial course, which contracted in response to electrical stimulation.

First, we optimised the composition of biomaterials utilized in the development and the electrical stimulation utilized to the tissue throughout tradition. Subsequently, we fabricated millimetre-thick bovine muscle tissues containing extremely aligned myotubes by accumulating bovine myoblast-laden hydrogel modules. The microbial content material of the bovine muscle tissue cultured for 14 days was beneath the detection restrict, indicating that the muscle tissues have been sterile, not like business meat. Therefore, the proposed development technique for bovine muscle tissues can be helpful for the manufacturing of clear cultured steak meat simulating actual meat.

The synergistic union of nanomaterials with biomaterials has revolutionized artificial chemistry, enabling the creation of nanomaterial-based biohybrids with distinct properties for biomedical functions. This class of supplies has drawn vital scientific curiosity from the perspective of purposeful extension by way of controllable coupling of artificial and biomaterial parts, leading to enhancement of the chemical, bodily, and organic properties of the obtained biohybrids.

In this overview, we spotlight the forefront supplies for the mixture with biomacromolecules and residing organisms and their advantageous properties in addition to latest advances in the rational design and synthesis of synthetic biohybrids. We additional illustrate the unbelievable variety of biomedical functions stemming from artificially bioaugmented traits of the nanomaterial-based biohybrids. Eventually, we intention to encourage scientists with the software horizons of the thrilling subject of artificial augmented biohybrids.

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

Current Insights Into 3D Bioprinting: An Advanced Approach for Eye Tissue Regeneration

Three-dimensional (3D) printing is a recreation changer expertise that holds nice promise for all kinds of biomedical functions, together with ophthalmology. Through this rising method, particular eye tissues will be custom-fabricated in a versatile and automated method, incorporating completely different cell varieties and biomaterials in exact anatomical 3D geometries. However, and regardless of the nice progress and prospects generated lately, there are nonetheless challenges to beat that jeopardize its scientific software in common apply. The predominant aim of this overview is to offer an in-depth understanding of the present standing and implementation of 3D bioprinting expertise in the ophthalmology subject in an effort to manufacture related tissues reminiscent of cornea, retina and conjunctiva.

Goat IgG Isotype Control

GWB-B5EB81 100 TESTS Ask for price

Goat IgG Isotype Control

GWB-9C0B03 100 TESTS Ask for price

Goat IgG Isotype Control

GWB-7B95C3 0.5 mg Ask for price

Goat IgG Isotype Control

GWB-E035B6 100 TESTS Ask for price

Goat IgG Isotype Control

GWB-D15A0C 100 TESTS Ask for price

PE Goat IgG Isotype Control

E16FGCP006-100 100 tests
EUR 368.33
Description: Available in various conjugation types.

Goat F(ab )2 IgG Isotype Control

GWB-4FA356 100 TESTS Ask for price

Goat F(ab')2 IgG Isotype Control

abx405076-05mg 0.5 mg
EUR 493.2

Goat F(ab )2 IgG Isotype Control

GWB-B1F87E 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control

GWB-A21E37 0.5 mg Ask for price

Goat F(ab )2 IgG Isotype Control

GWB-ECE6CB 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control

GWB-827F32 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control

GWB-953EBC 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control

GWB-712793 100 TESTS Ask for price

Goat F(ab )2 IgG Isotype Control

GWB-CF433F 5 mg Ask for price

Goat F(ab')2 IgG Isotype Control

abx405076-250g 250 µg
EUR 300

Goat IgG-PE conjugate (isotype control)

20011-PE 100 tests
EUR 270

Goat IgG-HRP conjugate (isotype control)

20011-HP 100 ug
EUR 196.8

Goat F(ab')2 IgG Isotype Control (PE)

abx405078-100g 100 µg
EUR 437.5

Goat IgG-FITC conjugate (isotype control)

20011-F 100 ug
EUR 196.8

Goat F(ab')2 IgG Isotype Control (RPE)

abx405078-05ml 0.5 ml
EUR 644.4

Goat F(ab')2 IgG Isotype Control (FITC)

abx405077-100tests 100 tests
EUR 594

Goat F(ab')2 IgG Isotype Control (FITC)

abx405077-100g 100 µg
EUR 387.5

Alexa Fluor® 647 Goat IgG Isotype Control

E16FGCK006-100 100 tests
EUR 563.33
Description: Available in various conjugation types.

Goat IgG (fc)-HRP conjugate (isotype control)

20011-Fc-HP 100 ug
EUR 196.8

Normal Goat Polyclonal Isotype Control IgG

nAP-0014 1mg
EUR 459

Goat IgG (fc)-FITC conjugate (isotype control)

20011-Fc-F 100 ug
EUR 196.8

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 123.6

Goat IgG (fc)-Biotin conjugate (isotype control)

20011-Fc-B 100 ug
EUR 196.8

Goat IgG, purified (serum non-immune, isotype control)

20011-25 25 mg
EUR 562.8

Goat IgG, purified (serum non-immune, isotype control)

20011-5 5 mg
EUR 343.2

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 242.4

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 196.8

Rat IgG Isotype Control

31-AR15 10 mg
EUR 183
Description: Purified Rat IgG Isotype Control

Rat IgG Isotype Control

GWB-37FCE4 10 mg Ask for price

Rat IgG Isotype Control

GWB-4BFFB2 0.5 mg Ask for price

Rat IgG Isotype Control

GWB-1E8B74 0.1 mg Ask for price

Rat IgG Isotype Control

GWB-B6F703 0.1 mg Ask for price

Dog IgG Isotype Control

GWB-323C1E 5 mg Ask for price

Rat IgG Isotype Control

GWB-7A6404 0.1 mg Ask for price

Rat IgG Isotype Control

GWB-D9CFB7 0.1 mg Ask for price

Rat IgG Isotype Control

GWB-76BDF3 0.1 mg Ask for price

Rat IgG Isotype Control

GWB-787682 0.1 mg Ask for price

Rat IgG Isotype Control

GWB-F39C54 0.5 mg Ask for price

Rat IgG Isotype Control

GWB-F7A192 0.5 mg Ask for price

Rat IgG Isotype Control

GWB-CFDA81 0.1 mg Ask for price

Rat IgG Isotype Control

GWB-BEE47C 0.1 mg Ask for price

OOSA10406-500UG - GOAT F(ab')2 IgG NEGATIVE CONTROL Negative/Isotype Control

OOSA10406-500UG 0.5mg
EUR 339

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 196.8

Human IgG Isotype Control

GWB-2CF422 1.0 mg Ask for price

Mouse IgG Isotype Control

GWB-2F1CBA 0.1 mg Ask for price

Mouse IgG Isotype Control

GWB-552B59 0.1 mg Ask for price

Human IgG Isotype Control

GWB-38F945 1 ml Ask for price

Mouse IgG Isotype Control

GWB-4662CD 0.1 mg Ask for price

Mouse IgG Isotype Control

GWB-46ECA9 0.5 mg Ask for price

Mouse IgG Isotype Control

GWB-1B0AB3 0.5 mg Ask for price

Mouse IgG Isotype Control

GWB-1BE5E5 10 mg Ask for price

Sheep IgG Isotype Control

GWB-1E6DA3 1 mg Ask for price

Sheep IgG Isotype Control

GWB-9688FE 0.1 mg Ask for price

Mouse IgG Isotype Control

GWB-E00547 1 ml Ask for price

Mouse IgG Isotype Control

GWB-EDB4A9 0.5 mg Ask for price

Mouse IgG Isotype Control

GWB-949104 0.1 mg Ask for price

Sheep IgG Isotype Control

GWB-710114 5 mg Ask for price

Mouse IgG Isotype Control

GWB-75892E 0.1 mg Ask for price

Mouse IgG Isotype Control

GWB-D166E3 0.1 mg Ask for price

Human IgG Isotype Control

GWB-BDF954 1 ml Ask for price

Mouse IgG Isotype Control

GWB-BEF412 0.1 mg Ask for price

Mouse IgG Isotype Control

IC002-100ul 100ul
EUR 146.4

Mouse IgG Isotype Control

abx127121-100l 100 µl
EUR 150

Mouse IgG Isotype Control

abx127121-1ml 1 ml Ask for price

Mouse IgG Isotype Control

abx127121-200l 200 µl Ask for price

Human IgG Isotype Control

DAGIC1333 10 mg
EUR 724.5
Description: Human

Rabbit IgG Isotype Control

GWB-1EF918 100 TESTS Ask for price

Rabbit IgG Isotype Control

GWB-12A897 100 TESTS Ask for price

Rabbit IgG isotype control

AC042 100μL
EUR 292.5
Description: None

Rabbit IgG Isotype Control

abx125003-100ul 100 ul
EUR 243.6

Rabbit IgG Isotype Control

GWB-F3BC41 10 mg Ask for price

Rabbit IgG Isotype Control

IC001-100ul 100ul
EUR 146.4

Rabbit IgG Isotype Control

abx125003-100l 100 µl
EUR 150

Rabbit IgG Isotype Control

abx125003-1ml 1 ml Ask for price

Rabbit IgG Isotype Control

abx125003-200l 200 µl Ask for price

Rabbit IgG Isotype Control

CABT-B8382 500 µg
EUR 598.5
Description: Rabbit

Hamster IgG Isotype Control

GWB-528DB9 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-419E75 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-47E59E 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-4DBCD9 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-1A8D7A 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-30C10C 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-3114BE 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-3413D0 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-6571A8 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-EE081F 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-C224BD 0.1 mg Ask for price

IgG Isotype Control antibody

10R-6524 50 ug
EUR 123
Description: Armenian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody

10R-6525 50 ug
EUR 123
Description: Syrian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody (PE)

61R-1337 200 ug
EUR 224
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (PE)

61R-1338 50 ug
EUR 224
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (PE)

FITC Rabbit IgG - Isotype control

DB-1000 100 tests
EUR 506.4

FITC Rabbit IgG - Isotype control

DB1000 100 tests
EUR 506.4

Rabbit IgG Isotype Control (FITC)

abx227001-100g 100 µg
EUR 225

IgG Isotype Control antibody (FITC)

61R-1136 50 ug
EUR 201
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (FITC)

IgG Isotype Control antibody (FITC)

61R-1800 25 ug
EUR 175
Description: Rabbit polyclonal IgG Isotype Control antibody (FITC)

Hamster (Syrian) IgG Isotype Control

abx405032-025mg 0.25 mg
EUR 460.8

Syrian Hamster IgG Isotype Control

SIGGA-100 100 µg
EUR 688.99

Syrian Hamster IgG Isotype Control

SIGGB-200 200 µg
EUR 566.69

Syrian Hamster IgG Isotype Control

SIGGF-200 200 µg
EUR 654.05

Syrian Hamster IgG Isotype Control

SIGGPE-100 100 µg
EUR 619.1

Syrian Hamster IgG Isotype Control

SIGGPP5.5-100 100 µg
EUR 811.3

Syrian Hamster IgG Isotype Control

SIGGPP5.5-25 25 µg
EUR 426.91

Syrian Hamster IgG Isotype Control

SIGGPU-500 500 µg
EUR 514.27

IgG Isotype Control antibody (biotin)

61R-1586 50 ug
EUR 198
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (biotin)

Special consideration is paid to the description of the mostly employed bioprinting strategies, and the most related eye tissue engineering research carried out by 3D bioprinting expertise at preclinical stage. In addition, different related points associated to make use of of 3D bioprinting for ocular drug supply, in addition to each moral and regulatory points, are analyzed. Through this overview, we intention to lift consciousness amongst the analysis neighborhood and report latest advances and future instructions in an effort to apply this superior remedy in the eye tissue regeneration subject.


In vivo biocompatibility and biodegradability of poly(lactic acid)/poly(ε-caprolactone) blend compatibilized with poly(ε-caprolactone- b-tetrahydrofuran) in Wistar rats

In vivo biocompatibility and biodegradability of poly(lactic acid)/poly(ε-caprolactone) blend compatibilized with poly(ε-caprolactone- b-tetrahydrofuran) in Wistar rats

Poly(lactic acid) (PLA) and poly(ɛ-caprolactone) (PCL) are two necessary aliphatic esters identified for his or her biodegradability and bioresorbability properties; the previous is stiffer and brittle whereas the smaller modulus of the latter permits an appropriate elongation. The new biomaterials being developed from the blend of these two polymers (PLA and PCL) is opportune because of the decreasing interfacial stress between their immiscible phases. In a earlier research, PLA/PCL immiscible blend when compatibilized with poly(ε-caprolactone-b-tetrahydrofuran) resulted in enhanced ductility and toughness no cytotoxic impact in vitro exams. There is little printed knowledge on the impact of poly(ε-caprolactone-b-tetrahydrofuran) on PLA and PCL biocompatibility and biodegradability in vivo exams.

This research focuses on evaluating the behavioral response and polymer-tissue interplay of compatibilized PLA/PCL blend in comparison with neat PLA implanted by way of intraperitoneal (IP) and subcutaneous (SC) in male Wistar rats, distributed in 4 experimental teams: neat PLA, PLA/PCL blend, sham, and management at 2-, 8- and 24-weeks post-implantation (WPI). Open-field take a look at was carried out to appraise emotionality and spontaneous locomotor exercise. Histopathological investigation utilizing hematoxylin-eosin (H&E) and picrosirius-hematoxylin (PSH) was used to evaluate polymer-tissue interplay. Modifications in PLA and the PLA / PCL blend’s floor morphology have been decided by scanning electron microscopy (SEM).

PLA group defecated extra typically than PLA/PCL rats 2 and Eight WPI. Conjunctive capsule growth round implants, cell adhesion, angiogenesis, and big cells of a international physique to the biomaterial was noticed in gentle microscopy. Both teams displayed a fibrous response alongside with collagen deposition across the biomaterials. In the SEM, the photographs confirmed a better degradation price for the PLA/PCL blend in each implantation routes. The polymers implanted by way of IP exhibited a better degradation price in comparison with SC. These findings emphasize the biocompatibility of the PLA/PCL blend compatibilized with poly(ε-caprolactone-b-tetrahydrofuran), making this biopolymer an appropriate different in a range of biomedical applicatio.

Design issues for engineering 3D fashions to check vascular pathologies in vitro

Many cardiovascular ailments (CVD) are pushed by pathological remodelling of blood vessels, which might result in aneurysms, myocardial infarction, ischaemia and strokes. Aberrant remodelling is pushed by adjustments in vascular cell behaviours mixed with degradation, modification, or irregular deposition of extracellular matrix (ECM) proteins. The underlying mechanisms that drive the pathological remodelling of blood vessels are multifaceted and illness particular; nevertheless, unravelling them could also be key to growing therapies. Reductionist fashions of blood vessels created in vitro that mix cells with biomaterial scaffolds could function helpful analogues to check vascular illness development in a managed setting.
This evaluate presents the primary issues for growing such in vitro fashions. We talk about how the design of blood vessel fashions impacts experimental readouts, with a specific give attention to the upkeep of regular mobile phenotypes, methods that mimic regular cell-ECM interactions, and approaches that foster intercellular communication between vascular cell varieties. We additionally spotlight how selection of biomaterials, mobile preparations and the inclusion of mechanical stimulation utilizing fluidic gadgets collectively impression the flexibility of blood vessel fashions to imitate in vivo circumstances. In the longer term, by combining advances in supplies science, cell biology, fluidics and modelling, it might be attainable to create blood vessel fashions which are patient-specific and can be utilized to develop and take a look at therapies.
In vivo biocompatibility and biodegradability of poly(lactic acid)/poly(ε-caprolactone) blend compatibilized with poly(ε-caprolactone- b-tetrahydrofuran) in Wistar rats

Repair of segmental bone defect utilizing tissue engineered heterogeneous deproteinized bone doped with lithium

Lithium have been proven to play an necessary position in enhancing the osteogenic properties of biomaterials. This research goals to discover the osteogenic enchancment impact of tissue engineered heterogeneous deproteinized bone (HDPB) doped with lithium, and consider their effectiveness in the therapeutic of bone defects. Bone marrow mesenchymal stem cells (BMSCs) have been co-cultured with totally different focus of lithium chloride. Cell proliferation in every group was analyzed by 3-(4, 5-dimetyl-2-thiazoly-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay.

BMSCs have been then co-cultured in osteogenic induction medium with totally different focus of lithium chloride, and the expression of associated mRNA was detected. The position of lithium in selling BMSCs osteogenic differentiation and inhibiting BMSCs lipogenic differentiation was additionally investigated. Biomechanical properties of the tibia have been evaluated at Eight weeks after operation. The tibial specimens of every group have been collected at 4 and Eight weeks after surgical procedure for histological examination and histological evaluation.

Micro-computed tomography (CT) scanning and 3D reconstruction have been carried out at Eight weeks. The outcomes display that lithium can induce the osteogenic differentiation inhibit of adipogenic differentiation of BMSCs by regulating the Wnt signaling pathway. The histological analysis additional licensed that common bone formation space in the group of tissue engineered HDPB doped with lithium was additionally considerably higher than that of HDPB alone group. Based on the above analysis, tissue engineered HDPB doped with lithium can successfully promote the regeneration of segmental bone defect, which can be utilized as a tissue engineering scaffold for medical trials.

RFP Control Lentivirus (Puro)

LV096 4 x 500 ul
EUR 195

CMV control lentivirus (Hygro)

CMV-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

EF1a control lentivirus (Hygro)

EF1a-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

RFP (mRuby3) Control Lentivirus

LV101 4 x 500 ul
EUR 195

CAR negative control: CD28-CD3ζ (GFP-Puro) Lentivirus

CAR-ctr8 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, containing GFP-Puromycin dual selection

RFP (TagRFP-T) Control Lentivirus

LV097 4 x 500 ul
EUR 195

CAR negative control: 4-1BB-CD3ζ (GFP-Puro) Lentivirus

CAR-ctr7 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (4-1BB) control lentivirus without targeting domain, containing GFP-Puromycin dual selection

Negative Control Luciferase Lentivirus

79578 500 µl x 2
EUR 860
Description: The Negative Control Lentivirus (Firefly Luciferase) are replication incompetent, HIV-based, VSV-G pseudo typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of a minimal TATA promoter, without any additional transcriptional response elements.

CMV control lentivirus (No Selection)

CMV-Null- 1 x10^7 IFU/ml x 200ul
EUR 206.5
Description: Negative control lentivirus under CMV promoter, does not contain any antibiotic selection.

Negative Control eGFP Reporter Lentivirus

79927 500 µl x 2
EUR 835
Description: The Negative Control eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced Green Fluorescent Protein (eGFP) gene under the control of a minimal TATA promoter, without any additional transcriptional response elements.

Expression Negative Control Lentivirus (G418)

79902-G 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

Expression Negative Control Lentivirus (Puromycin)

79902-P 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

Expression Negative Control Lentivirus (Hygromycin)

79902-H 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

CAR negative control: CD28-CD3ζ (No Select) Lentivirus

CAR-ctr6 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, does not contain any antibiotic selection

CMV Control (No Antibiotic), Concentrated Lentivirus in PBS

CMV-Null-PBS 1 x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Negative control lentivirus under CMV promoter, contains no any antibioic selection.

EF1a Control (No Antibiotic), Concentrated Lentivirus in PBS

EF1a-Null-PBS 1 x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Negative control lentivirus under EF1a promoter, contains no any antibioic selection.

CAR negative control: 4-1BB-CD3ζ (No Select) Lentivirus

CAR-ctr5 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (4-1BB) control lentivirus without targeting domain, do not any antibiotic selection

AR-RFP (GFP) Lentivirus 

LVP913-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AR-Luc (GFP) Lentivirus 

LVP914-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

G_RE-RFP (GFP) Lentivirus 

LVP950-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter embedded 4 tandem repeats of glucocorticoid response element (G-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

G_RE-Luc (GFP) Lentivirus 

LVP951-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter embedded 4 tandem repeats of glucocorticoid response element (G-RE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

H_RE-RFP (GFP) Lentivirus 

LVP970-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 6 tandem repeats of hypoxia transcriptional response element (H-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

H_RE-Luc (GFP) Lentivirus 

LVP971-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 6 tandem repeats of hypoxia transcriptional response element (H-RE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-RFP (GFP) Lentivirus 

LVP974-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of estrogen receptor response element (ER-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-Luc (GFP) Lentivirus 

LVP975-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of estrogen receptor response element (ER-RE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

MB-RFP (GFP) Lentivirus 

LVP1022-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human Myoglobin 's promoter which only expressed in muscle, predominantly in cardiac and skeletal myocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

MB-Luc (GFP) Lentivirus 

LVP1023-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human Myoglobin 's promoter which only expressed in muscle, predominantly in cardiac and skeletal myocytes. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

HE4-RFP (GFP) Lentivirus 

LVP1042-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human HE4's promoter which is overexpressed in ovarian cancer cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

HE4-Luc (GFP) Lentivirus 

LVP1043-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human HE4's promoter which is overexpressed in ovarian cancer cells. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

PSA-RFP (GFP) Lentivirus 

LVP1046-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human PSA's promoter which expressed in normal prostate epithelium and prostate cancers. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

PSA-Luc (GFP) Lentivirus 

LVP1047-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human PSA's promoter which expressed in normal prostate epithelium and prostate cancers. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AR-Rluc (GFP) Lentivirus 

LVP915-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the minimal promoter contains 4 tandem repeats of Androgen Response Element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Gli-RFP (GFP) Lentivirus 

LVP946-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter embeded 8 tandem repeats of Gli responsive element (hedgehog pathway). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Gli-Luc (GFP) Lentivirus 

LVP947-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter embeded 8 tandem repeats of Gli responsive element (hedgehog pathway). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

G_RE-Rluc (GFP) Lentivirus 

LVP952-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter embedded 4 tandem repeats of glucocorticoid response element (G-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AP1-RFP (GFP) Lentivirus 

LVP954-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 8 tandem repeats of AP1 Responsive Element (AP1-RE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AP1-Luc (GFP) Lentivirus 

LVP955-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 8 tandem repeats of AP1 Responsive Element (AP1-RE) . This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SRE-RFP (GFP) Lentivirus 

LVP958-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of serum response element (SRE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SRE-Luc (GFP) Lentivirus 

LVP959-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of serum response element (SRE) . This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

RBP_JK-RFP (GFP) Lentivirus 

LVP962-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of RBP-JK transcriptional responsive element (RBP-JK TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

RBP_JK-Luc (GFP) Lentivirus 

LVP963-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of RBP-JK transcriptional responsive element (RBP-JK TRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

H_RE-Rluc (GFP) Lentivirus 

LVP972-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 6 tandem repeats of hypoxia transcriptional response element (H-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-Rluc (GFP) Lentivirus 

LVP976-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of estrogen receptor response element (ER-RE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

P53-RFP (GFP) Lentivirus 

LVP978-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded with optimized tandem repeats of a few most potent P53 transcriptional response element. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

P53-Luc (GFP) Lentivirus 

LVP979-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded with optimized tandem repeats of a few most potent P53 transcriptional response element. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ARE-RFP (GFP) Lentivirus 

LVP982-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ARE-Luc (GFP) Lentivirus 

LVP983-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

B29-RFP (GFP) Lentivirus 

LVP994-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a human Immunoglobulin gene's promoter which demonstrates B-cell specific expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

B29-Luc (GFP) Lentivirus 

LVP995-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a human Immunoglobulin gene's promoter which demonstrates B-cell specific expression. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

MB-Rluc (GFP) Lentivirus 

LVP1024-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human Myoglobin 's promoter which only expressed in muscle, predominantly in cardiac and skeletal myocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SPB-RFP (GFP) Lentivirus 

LVP1026-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human Surfactant protein B's promoter which selectively expressed in bronchiolar and alveolar epithelial cells of the lung. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SPB-Luc (GFP) Lentivirus 

LVP1027-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human Surfactant protein B's promoter which selectively expressed in bronchiolar and alveolar epithelial cells of the lung. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

aFP-RFP (GFP) Lentivirus 

LVP1034-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human alpha-fetoprotein 's promoter which used for the expression into hepatocellular carcinoma cells . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

aFP-Luc (GFP) Lentivirus 

LVP1035-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human alpha-fetoprotein 's promoter which used for the expression into hepatocellular carcinoma cells . This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

aFP-Rluc (GFP) Lentivirus 

LVP1036-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human alpha-fetoprotein 's promoter which used for the expression into hepatocellular carcinoma cells . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

HE4-Rluc (GFP) Lentivirus 

LVP1044-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human HE4's promoter which is overexpressed in ovarian cancer cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

PSA-Rluc (GFP) Lentivirus 

LVP1048-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human PSA's promoter which expressed in normal prostate epithelium and prostate cancers. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-RFP (GFP) Lentivirus 

LVP1120-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains another fluorescent marker GFP under RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-RFP (GFP) Lentivirus 

LVP1120-G-PBS 1x108 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express RFP reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains another fluorescent marker GFP under RSV promoter, provided in PBS solution.

EGR1-Luc (GFP) Lentivirus 

LVP1121-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-Luc (GFP) Lentivirus 

LVP1121-G-PBS 1x108 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express Firefly Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in PBS solution.

GFAP-RFP (GFP) Lentivirus 

LVP1126-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GFAP-RFP (GFP) Lentivirus 

LVP1126-G-PBS 1x108 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express RFP reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

GFAP-Luc (GFP) Lentivirus 

LVP1127-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GFAP-Luc (GFP) Lentivirus 

LVP1127-G-PBS 1x108 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express Firefly luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter. Lentivirus concentrated and provided in PBS solution.

ISRE-RFP (GFP) Lentivirus 

LVP938-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter undera minimal promoter embeded 8 tandem repeats of ISRE (Interferon Stimulated Response Element). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ISRE-Luc (GFP) Lentivirus 

LVP939-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter undera minimal promoter embeded 8 tandem repeats of ISRE (Interferon Stimulated Response Element). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CRE_TRE-RFP (GFP) Lentivirus 

LVP942-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter embeded 8 tandem repeats of cAMP response motif (CRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CRE_TRE-Luc (GFP) Lentivirus 

LVP943-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter embeded 8 tandem repeats of cAMP response motif (CRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Gli-Rluc (GFP) Lentivirus 

LVP948-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter embeded 8 tandem repeats of Gli responsive element (hedgehog pathway). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

AP1-Rluc (GFP) Lentivirus 

LVP956-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 8 tandem repeats of AP1 Responsive Element (AP1-RE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SRE-Rluc (GFP) Lentivirus 

LVP960-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of serum response element (SRE) . This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

RBP_JK-Rluc (GFP) Lentivirus 

LVP964-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of RBP-JK transcriptional responsive element (RBP-JK TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

NFkB-RFP (GFP) Lentivirus 

LVP966-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 4 tandem repeats of NFκB transcriptional response element (NFkB-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

NFkB-Luc (GFP) Lentivirus 

LVP967-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 4 tandem repeats of NFκB transcriptional response element (NFkB-TRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

P53-Rluc (GFP) Lentivirus 

LVP980-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded with optimized tandem repeats of a few most potent P53 transcriptional response element. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ARE-Rluc (GFP) Lentivirus 

LVP984-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of antioxidant response element (ARE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CEBP-RFP (GFP) Lentivirus 

LVP986-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under a minimal promoter that embedded 8 tandem repeats of C/EBP transcriptional response element (C/EBP-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CEBP-Luc (GFP) Lentivirus 

LVP987-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under a minimal promoter that embedded 8 tandem repeats of C/EBP transcriptional response element (C/EBP-TRE). This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

B29-Rluc (GFP) Lentivirus 

LVP996-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a human Immunoglobulin gene's promoter which demonstrates B-cell specific expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD14-RFP (GFP) Lentivirus 

LVP998-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD14-Luc (GFP) Lentivirus 

LVP999-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD43-RFP (GFP) Lentivirus 

LVP1002-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD43-Luc (GFP) Lentivirus 

LVP1003-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD45-RFP (GFP) Lentivirus 

LVP1006-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD45-Luc (GFP) Lentivirus 

LVP1007-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD68-RFP (GFP) Lentivirus 

LVP1010-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the human CD68's promoter which expressed specifically in macrophages and macrophage-related cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD68-Luc (GFP) Lentivirus 

LVP1011-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the human CD68's promoter which expressed specifically in macrophages and macrophage-related cells. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Flt1-RFP (GFP) Lentivirus 

LVP1014-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the human Flt-1's promoter which expressed specifically in endothelial cells and up-regulated in tumor vasculature. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Flt1-Luc (GFP) Lentivirus 

LVP1015-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the human Flt-1's promoter which expressed specifically in endothelial cells and up-regulated in tumor vasculature. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SPB-Rluc (GFP) Lentivirus 

LVP1028-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human Surfactant protein B's promoter which selectively expressed in bronchiolar and alveolar epithelial cells of the lung. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SYN1-RFP (GFP) Lentivirus 

LVP1030-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human Synapsin 's promoter which used for neuron-specific high expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SYN1-Luc (GFP) Lentivirus 

LVP1031-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human Synapsin 's promoter which used for neuron-specific high expression. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CCKAR-RFP (GFP) Lentivirus 

LVP1038-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human CCKR's promoter which is predominantly expressed in human pancreatic cancer. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CCKAR-Luc (GFP) Lentivirus 

LVP1039-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human CCKR's promoter which is predominantly expressed in human pancreatic cancer. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-Rluc (GFP) Lentivirus 

LVP1122-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EGR1-Rluc (GFP) Lentivirus 

LVP1122-G-PBS 1x108 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express Renilla Luciferase reporter under the promoter of human early growth response gene-1 (EGR1). This lentivirus contains the fluorescent marker GFP under RSV promoter, provided in PBS solution.

GFAP-Rluc (GFP) Lentivirus 

LVP1128-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GFAP-Rluc (GFP) Lentivirus 

LVP1128-G-PBS 1x108 IFU/ml x 200ul
EUR 852
Description: Pre-made lentivirus express Renilla luciferase reporter under human GFAP's promoter which expressed in astrocytes in Central Nervous System. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter. Lentivirus concentrated and provided in PBS solution.

ISRE-Rluc (GFP) Lentivirus 

LVP940-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter undera minimal promoter embeded 8 tandem repeats of ISRE (Interferon Stimulated Response Element). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CRE_TRE-Rluc (GFP) Lentivirus 

LVP944-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter embeded 8 tandem repeats of cAMP response motif (CRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

NFkB-Rluc (GFP) Lentivirus 

LVP968-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 4 tandem repeats of NFκB transcriptional response element (NFkB-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CEBP-Rluc (GFP) Lentivirus 

LVP988-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under a minimal promoter that embedded 8 tandem repeats of C/EBP transcriptional response element (C/EBP-TRE). This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GATA2-RFP (GFP) Lentivirus 

LVP990-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under GATA-2 promoter which dynamically expressed in hematopoietic tissues and in the central nervous system. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GATA2-Luc (GFP) Lentivirus 

LVP991-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under GATA-2 promoter which dynamically expressed in hematopoietic tissues and in the central nervous system. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD14-Rluc (GFP) Lentivirus 

LVP1000-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD14 promoter which demonstrates strongly upregulated expression during monocytic cell differentiation. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD43-Rluc (GFP) Lentivirus 

LVP1004-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD43 promoter which expressed on the surface of leukocytes and platelets.. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD45-Rluc (GFP) Lentivirus 

LVP1008-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD45's promoter which expressed exclusively by all hematopoietic cells except erythrocytes and platelets. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CD68-Rluc (GFP) Lentivirus 

LVP1012-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the human CD68's promoter which expressed specifically in macrophages and macrophage-related cells. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Flt1-Rluc (GFP) Lentivirus 

LVP1016-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the human Flt-1's promoter which expressed specifically in endothelial cells and up-regulated in tumor vasculature. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ICAM2-RFP (GFP) Lentivirus 

LVP1018-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under the human ICAM-2's promoter which expressed specifically in vasculature endothelial cells and megakaryocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ICAM2-Luc (GFP) Lentivirus 

LVP1019-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under the human ICAM-2's promoter which expressed specifically in vasculature endothelial cells and megakaryocytes. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

SYN1-Rluc (GFP) Lentivirus 

LVP1032-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human Synapsin 's promoter which used for neuron-specific high expression. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CMV Promoter GFP Lentivirus

G373 200 μl, Titer: 1x10^7 IU/ml
EUR 475
Description: N/A

UbC Promoter GFP Lentivirus

G383 200 μl, Titer: 1x10^7 IU/ml
EUR 475
Description: N/A

PGK Promoter GFP Lentivirus

G384 200 μl, Titer: 1x10^7 IU/ml
EUR 475
Description: N/A

CCKAR-Rluc (GFP) Lentivirus 

LVP1040-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under human CCKR's promoter which is predominantly expressed in human pancreatic cancer. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CamKII-RFP (GFP) Lentivirus 

LVP1054-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express RFP reporter under human CamKII's promoter which restrictly expressed in neurons of the neocortex and hippocampus, also pyramidal neurons. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CamKII-Luc (GFP) Lentivirus 

LVP1055-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Firefly luciferase reporter under human CamKII's promoter which restrictly expressed in neurons of the neocortex and hippocampus, also pyramidal neurons. This lentivirus also contain the GFP selection marker under the consitutiveRSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

GATA2-Rluc (GFP) Lentivirus 

LVP992-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under GATA-2 promoter which dynamically expressed in hematopoietic tissues and in the central nervous system. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ICAM2-Rluc (GFP) Lentivirus 

LVP1020-G 1x107 IFU/ml x 200ul
EUR 662.4
Description: Pre-made lentivirus express Renilla luciferase reporter under the human ICAM-2's promoter which expressed specifically in vasculature endothelial cells and megakaryocytes. This lentivirus also contain the GFP selection marker under the consitutive RSV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Enhanced GFP Lentivirus (G418)

78639-G 500 µl x 2
EUR 835
Description: Enhanced green fluorescent protein (eGFP) is a modified (F64L and S65T mutations) version of the native GFP protein isolated from jellyfish (Aequorea victoria), with increased fluorescence and more efficient folding. The Enhanced GFP Lentivirus are replication-incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express eGFP under a CMV promoter ). eGFP expression and transduction efficiency can easily be verified and optimized via fluorescence microscopy or flow cytometry. eGFP has an excitation wavelength of 488 nm, an emission wavelength of 509 nm, and extinction coefficient of 55,000 M-1cm-1.

Complex coacervation permits necessary moist adhesion processes in pure and synthetic methods. However, existed artificial coacervate adhesives present restricted moist adhesion properties, non-thermoresponsiveness, and inferior biodegradability, drastically hampering their translations. Herein, by harnessing supramolecular meeting and rational protein design, we current a temperature-sensitive moist bioadhesive fabricated via recombinant protein and surfactant. Mechanical efficiency of the bioglue system is actively tunable with thermal triggers.


Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials.

Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials.

Ischemic coronary heart illness is a standard reason behind end-stage coronary heart failure and has endured as one of many primary causes of finish stage coronary heart failure requiring transplantation.

Maladaptive myocardial transforming because of ischemic damage includes a number of cell sorts and physiologic mechanisms. Pathogenic post-infarct transforming includes collagen deposition, chamber dilatation and ventricular dysfunction. There have been important enhancements in medicine and revascularization methods.

However, regardless of medical optimization and alternatives to revive blood circulation, physicians lack therapies that straight entry and manipulate the guts to advertise wholesome post-infarct myocardial transforming.

Strategies are actually arising that use bioactive supplies to advertise cardiac regeneration by selling angiogenesis and inhibiting cardiac fibrosis; and many of those methods leverage the distinctive benefit of cardiac surgical procedure to straight visualize and manipulate the guts.

Although cellular-based methods are rising, a number of limitations exist for medical translation. Acellular supplies have additionally demonstrated preclinical therapeutic potential to advertise angiogenesis and attenuate fibrosis and might be able to surmount these translational limitations.

Within this evaluate we define numerous acellular biomaterials and we outline epicardial infarct restore and intramyocardial injection, which give attention to administering bioactive supplies to the cardiac epicardium and myocardium respectively to advertise cardiac regeneration.

In conjunction with optimized medical remedy and revascularization, these methods present promise to upregulate pathways of cardiac regeneration to protect coronary heart operate.

Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials.
Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials.

Self-defensive antimicrobial biomaterial surfaces.

Self-defensive biomaterial surfaces are being developed with a purpose to mitigate an infection related to tissue-contacting biomedical gadgets. Such an infection happens when microbes colonize the floor of a tool and proliferate right into a recalcitrant biofilm. A key intervention level facilities on stopping the preliminary colonization.

Incorporating antimicrobials inside a floor coating could be very efficient, however the conventional technique of antimicrobial supply by steady elution can usually be counterproductive. If there is no such thing as a an infection, steady elution creates circumstances that promote the event of resistant microbes all through the affected person. In distinction, a self-defensive coating releases antimicrobial solely when and solely the place there’s a microbial problem to the floor. Otherwise, the antimicrobial stays sequestered inside the coating and doesn’t contribute to the event of resistance.

A self-defensive floor requires a neighborhood set off that indicators the microbial problem. Three such triggers have been recognized as: (1) native pH decreasing; (2) native enzyme launch; and (3) direct microbial-surface contact. This quick evaluate highlights the necessity for self-defensive surfaces within the normal context of the device-infection drawback and then opinions key biomaterials developments related to every of those three triggering mechanisms.